Information Sheet

This information sheet illustrates CDC’s new recommendations for laboratories to capitalize on the latest available technologies in HIV testing to help diagnose infections as much as 3-4 weeks sooner than the previous testing approach. Early diagnosis is critical since many new infections are transmitted by people in the earliest (“acute”) stage of infection.

This information sheet discusses the Xpert MTB/RIF Assay for diagnosing TB. It explains that the new test is a nucleic acid amplification test that diagnoses TB in less than 2 hours and can also determine resistance to rifampin, one of the drugs used to treat TB. The information sheet describes how the Xpert MTB/RIF assay works, its advantages, how the results should be interpreted, what it means if RIF resistance is detected, not detected, or is indeterminate. Addresses for additional information are provided.

This information sheet discusses testing and diagnosing hepatitis C virus infection (HCV). It describes hepatitis C, a serious liver disease, and notes that some people do not know they have disease because they experience no symptoms. The information sheet explains hepatitis C transmission, who should be tested, why it is important to be tested, the blood test doctors use to diagnose HCV and the meaning of the test results, and where to find additional information.

This information sheet discusses testing and diagnosing hepatitis C virus infection (HBV). It describes hepatitis C, a serious liver disease, and notes that some people do not know they have disease because they experience no symptoms. The information sheet explains hepatitis C transmission, who should be tested, why it is important to be tested, the blood test doctors use to diagnose HCV and the meaning of the test results, and where to find additional information.

This information sheet discusses the liver biopsy. It explains a liver biopsy; the risks involved; how a liver biopsy can help, particularly for people with Hepatitis C; how it is done; and what happens after the liver biopsy is done. It also discusses when one should not have a liver biopsy. The information sheet specially emphasizes that a person who takes medicine for hepatitis C might need to have more than one liver biopsy.

This information sheet describes good nutrition as being of great importance to a person with hepatitis C. It provides guidelines for healthy eating and drinking. It advises the following: Do not drink alcohol, avoid crash diets and/or binges, educate yourself about nutrition, eat a variety of foods, and drink plenty of water. It discusses overcoming barriers to eating well.

This pamphlet provides information on how veterans can cope when they have been diagnosed with hepatitis C. Some of the most common feelings associated with a diagnosis of hepatitis C are the following: sadness or depression, anger, fear, and anxiety. The pamphlet gives information on how to take care of your emotional needs, including talking about your feelings with your doctor, friends, family members, or other supportive people.

This information sheet explains how to get treatment through a clinical trial for the hepatitis C virus. It explains how clinical trials work and what the different types of clinical trials are. It discusses informed consent, cost, how to find clinical trials, and the benefits and risks of participating in a clinical trial.

This information sheet discusses hepatitis C, a viral infection that affects the liver. It answers the questions, why should one disclose a diagnosis of hepatitis C, who should be told and when, and what sorts of things to say. It also states where to get more information on hepatitis C.